Tissue Organoids as Models of Host Physiology and Pathophysiology of Disease
Organizer(s): Thaddeus S. Stappenbeck and Linda G. Griffith Date: January 19 - 23, 2020
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Tissue organoids are becoming an increasingly sophisticated experimental system that is of importance in investigative work on nearly every organ system. There has been a recent explosion of techniques and platforms that enable dissection of fundamental questions, modeling cellular alterations in disease states and screening of compounds and molecules to discover new pathways. Fundamental work into organoid properties has developed the potential of organoids to become new methods for diagnosis, therapeutic selection and even to serve as regenerative medicine therapeutics themselves. This conference will bring together experts in organoids from various tissues and will create valuable cross-fertilization of ideas and approaches that will benefit many fields. A major gap is that this technology is being siloed in areas of specific tissues and molecular pathways. A general conference that cuts across all organs and major utilities will be of high value and will encourage groups to share ideas across organ systems. The conference program will also include engineering approaches that will highlight novel developments in organoid technology. As a result of this conference, it is anticipated that participants will have a much better understanding of the capabilities of organoid systems and see new avenues for exploration. This conference is designed to emphasize synthesis over reductionism. An additional aim of this conference is to help investigators make the connection to develop new diagnostic and therapeutic tools using organoids.
Scholarship Deadline: September 25 2019
Discounted Abstract Deadline: September 25 2019
Abstract Deadline: October 17 2019
Discounted Registration Deadline: November 20 2019
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Grant No. 1R13EB029303-01
Funding for this conference was made possible (in part) by 1R13EB029303-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. This award is co-funded by the National Institute of Biomedical Imaging and Bioengineering and from the National Cancer Institute.